Introduction
The skin, as the interface of the human body with the external environment, carries part of our identity:
it provides information about our age, genetics, health status, lifestyle and even our emotional state (1) . The skin has different roles, among them, the function of barrier, thermoregulation, vitamin D synthesis and also protection of the body against harmful agents (2) (3) .
Currently, there is a growing interest on skin care products and their protective and healing properties, especially those with botanical extracts (4) . Among the latter, Chamomilla recutita (L.) rauschert (chamomile)
is a popular plant (5) which has its use as a phytotherapic released by the National Agency of Sanitary Surveillance (ANVISA) (6) . Chamomile has flavonoids, among which apigenin and apigenin-7-glycoside are the most abundant (7) . In different studies, these substances have proved to have antimicrobial (8) , analgesic (9) , antiinflammatory (6, 8, (10) (11) , cicatrizant (12) (13) , antitumor (14) (15) and immunomodulator (16) potential. Moreover, the antioxidant blend present in chamomile extract is effective in reducing free radicals and brings potential benefits when used in skin formulations by reducing water loss, improving hydration, and aiding the maintenance of the barrier function (4) .
The risks associated with the use of this plant are small and are related to the reduction of platelet aggregation (17) and anaphylactic reactions to people sensitive to its components (18) . However, a recent study that evaluated allergic reactions to herbal compounds over the last 27 years found no reports related to Chamomilla recutita (L.) rauschert (19) .
Despite the potential of apigenin and apigenin-7-glycoside, they have low stability (15, (20) (21) (22) . An alternative to improve this issue is the use of controlled release systems. The pharmaceutical sector, in line with technological developments, has gradually improved the processes of obtaining different products and invested in the forms of producing and applying them. To this end, microencapsulation is a widely used technology aimed at optimizing industrial processes as well as increasing the bioavailability and stability of the formulations. This process can be accomplished by different methods, using various coatings. In this study, the selected coating was chitosan and the method of production was spray drying (21) .
Chitosan is a biocompatible, biodegradable, lowtoxicity hydrophilic polysaccharide with mucoadhesive and film-forming properties (23) . Studies point to its potential in the treatment of skin lesions, with positive results in cicatrization and inflammatory response (24) (25) (26) (27) (28) .
This polymer was also used to coat microparticles containing endothelial and epidermal growth factors, with positive results in improving the cicatrization process (29) , and also as a coating of microparticles capable of capturing and expanding specific cells in order to accelerate the anti-inflammatory and cicatrization processes (30) .
Despite all the potentialities of chitosan-coated microparticles and the therapeutic properties of chamomile, no studies with these compounds were identified in the literature. These microparticles are incorporated in lanolin-based formulation, a safe substance for topical applications that incorporates various bioactive agents (31) .
In view of the above, a study was carried out to 
Method
Blind, controlled, non-randomized, single-dose Phase I clinical trial in which a low dose with biological activity of the active ingredient was administered (32) .
Extraction and microencapsulation methodologies developed and validated in a previous study were applied for the development of the microparticles used in this study (21) . Quality tests of the plant acquired according to the guidelines of the Brazilian Pharmacopoeia (34) were carried out in another study developed by the main author, as well as preliminary permeation and stability tests of the formulation in an ex vivo model. non-use of heparin, oral anticoagulants, and antiplatelet agents. The exclusion criteria were: injury at the sites of application, express intention to stop participation, and non-application of the product for more than four consecutive days. National (35) and international (32) recommendations about studies aiming at the initial evaluations of tolerance and safety in healthy humans were considered; the participation of 20 to 100 individuals is recommended. in the proximal portion of both, no product was applied to allow assessment of skin conditions (right negative control -C1; left negative control -C2). The dose was applied once a day, daily, always at the same time, and the participants were instructed not to use any other product at the application and evaluation sites during the 28 days of study.
Before each evaluation, all participants remained in a room with conditioned airat 24ºC (± 2ºC), with relative air humidity (RH) around 50% (± 4%), for 15 minutes. After 24 hours (D1) of the first application, the participants were evaluated for tolerance and onset of adverse reactions. If no complaints or signs of irritation were reported, the treatment was continued until the day D28, when the participants were re-evaluated.
The outcomes analyzed were skin irritation and a subjective evaluation of the participants regarding the sensation of hydration.
Quantitative measurements were performed by a pharmacist with experience in these analyses.
The clinical evaluation was done by a nurse and the subjective evaluation by the participants themselves.
All the results were annotated in a data collection However, contact with these participants was maintained up to 21 days after application, when the date of the final evaluation was confirmed. We emphasize that until that date, none of these four participants had manifested any adverse reaction to the treatment. The flow of participants is shown in Figure 2 . Firstly, an evaluation was carried out to identify possible differences in erythema, melanin, pH, hydration and transepidermal water loss between the four sites assessed at the beginning (D0) and at the end of the treatment (D28). These data are presented in Table 2 . .
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Concerning sex, 30 (85.7%) of the participants were female (Table 1) . Skin characteristics such as erythema, melanin, elasticity, thickness, transepidermal water loss and pH vary in the different anatomical sites between men and women and also in the different age groups (39) (40) (41) (42) . Authors point out the importance of considering variations in the biophysical properties of the skin at different ages, genders and anatomical locations because these differences are related to individual susceptibility to skin diseases; they should be considered in studies and in the production of skin products (41) .
The same occurs with BMI. This variable influences skin quality and, therefore, selecting a sample with a wide variation of BMI is important to understand the action of the product in a broader way. In this study, BMI also varied considerably, with a mean of 23. .
The evaluation of melanin showed a difference between the averages of the evaluated sites in both D0 (p = 0.0037) and D28 (p = 0.0053). These findings demonstrate that the amount of melanin was not homogeneous at the four sites evaluated at D0 and D28. Melanin levels may vary in the different parts of the body (41) . Besides anatomical issues, this fact can be explained by difference in sun exposure (41) , corroborating with the findings of this study. Personal factors such as age, sex, race, anatomical site and skin surface properties, as well as environmental factors such as light conditions, temperature, humidity and climatic variations can influence the color of the skin (41, 44) .
The function of melanin is the protection of the DNA of the keratinocytes against radiation (45) ; it is known that its concentration, its type and its location represent important factors in the evaluation of skin color, as well as in the evaluation of blood flow, thickness, softness and degradation of skin proteins (46) . A study that evaluated the effects of a tamarindcontaining emulsion on melanin identified a reduction in the amount of melanin at the application sites and attributed this result to the presence of phenolic compounds present in the extract (47) . It is known that chamomile contains several phenolic compounds in its composition, a fact that suggests the need for future studies to better investigate this property.
In the pH evaluation, there was no difference between the sites in D0 (p = 0.0819), but there was a significant difference in D28 (p = 0.0019). Furthermore, the mean pH of the skin was similar in the four sites evaluated at D0, but there was a change between values in D28, without, however, changing the physiological values. As this change was also verified in the control of the same arm, it can be inferred that this increase is not related to the use of the formulation. Furthermore, this alteration did not interfere in the values of pH normality in the skin.
pH is also a variable that varies in the different body regions (42) . In this study, it is believed that the difference is the result of the application of the formulation with chamomile, which caused an increase in its mean value, despite remaining within the physiological limits.
No significant alterations were found in the subjective evaluations of burning, pruritus and heat, or in the clinical evaluation of desquamation. It is known that the three components used are released by regulatory agencies, studied in different types of research and used for various purposes, among them skin treatments and care.
Chamomile extract was evaluated for toxicity, presenting safety at the dosages recommended for humans, without cytotoxic, genotoxic or mutagenic effects (48) . The use of chitosan in nanocapsules with alginate, for the treatment of infectious or inflammatory conditions of the skin showed antibacterial, antiinflammatory and controlled release activity, without causing skin irritation (49) . A study on the toxicity of lanolin and its effect on animal cicatrization concluded that it has no toxic effect on monocytes, important cells of the cicatrization process (50) .
As for the participant who was removed from the study in D1 due to a report of local reaction, the event is attributed to a possible unknown personal sensitivity to the components of the formulation, since this was an isolated case with spontaneous regression of signs. The participant who reported a sensation of pain indicated that the pain had a mild degree, with short duration, and it was spontaneously relieved. water loss at the four evaluated sites (pF1 = 0.0003, pC1 < 0.0001, pF2 = 0.0004 and pC2 < 0.0001), indicating a decrease of the function (Figure 3 ). Variations in transepidermal water loss can be attributed to blood flow, skin temperature, lipid content of the stratum corneum and degree of corneocyte formation (41) (42) . The increase in transepidermal water loss through the stratum corneum in the present study can be attributed to the period of the year and to the dry climate of the city in which the study was conducted. Studies maintaining a longer evaluation time may elucidate the possible influence of these aspects.
The comparison of the results of the four sites evaluated (Table 3) 
Conclusion
The hypothesis that the lanolin formulation,
containing Chamomilla recutita (L.) rauschert microparticles coated with chitosan would be safe for application to the intact skin of healthy volunteers was confirmed. Despite an isolated case of erythema, this event was not observed in other participants. There was alteration in melanin, attributed as protective effect of the formulation. There was no desquamation; one participant reported pain, with spontaneous and brief regression. The formulation did not cause pruritus or burning in the analyzed period.
The results showed an improvement in skin hydration at the application site of the formulation with chamomile; the subjective evaluation of the sensation of hydration by the volunteers at the end of the period was positive in all evaluated sites.
